Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast

August 2, 2022 at 8:25 AM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 2, 2022-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, will host a conference call on Tuesday, August 9th, 2022, at 4:30 pm ET to report its financial results for the second quarter of 2022.

Conference Call & Webcast Details


Tuesday, August 9th  


4:30 pm Eastern Time


Toll Free:

(800) 715-9871


(646) 307-1963

ID Number:


A live webcast of the conference call can be accessed in the Investors/ Media section of Infinity’s website at and will be available on Infinity's website for 30 days following the event.

Irina Koffler
LifeSci Advisors, LLC

Source: Infinity Pharmaceuticals, Inc.